Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
REXO1 like 1, pseudogene (REXO1L1P)
- Target
- REXO1L1P
- Molecular classification
- Other (Pseudogene)
01
Overview
REXO1 like 1, pseudogene (REXO1L1P) is a human gene classified as a pseudogene, meaning it is homologous to known protein-coding genes but is predicted not to produce a functional protein product. Its sequence suggests similarity to exonucleases—enzymes involved in nucleic acid processing—and it was initially hypothesized to encode a protein (putative exonuclease GOR) recognized as an antigen from chimpanzee serum, but this protein does not appear to be expressed in humans. REXO1L1P is annotated as potentially involved in rRNA 3'-end processing and predicted to be located in the cytoplasm and/or nucleus, but these functions are not experimentally confirmed and are based solely on sequence homology. REXO1L1P is not considered a therapeutic or pharmacological target and has no established biological, diagnostic, or disease relevance.
- Other names
- Putative exonuclease GORGORREXO1L1Antigen GOR homologRNA exonuclease 1 homolog-like 1
02
Biological functions
No known functional protein productpredicted exonuclease activity (not experimentally validated)predicted involvement in rRNA 3'-end processing
03
Disease associations
None establishedcurrently not implicated in specific diseases
Beyond the preview
Go deeper on REXO1 like 1, pseudogene (REXO1L1P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on REXO1 like 1, pseudogene (REXO1L1P).